Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry

Transpl Int. 2023 Oct 9:36:12088. doi: 10.3389/ti.2023.12088. eCollection 2023.

¹ Division of Cardiac Surgery, University Hospital of Verona, Verona, Italy.
² Division of Cardiac Surgery, S. Orsola University Hospital, IRCCS Bologna, Bologna, Italy.
³ City of Health and Science Hospital, Cardiac Surgery University Unit, University of Turin, Turin, Italy.
⁴ Division of Cardiac Surgery, Ospedale S. Maria della Misericordia, Udine, Italy.
⁵ Division of Cardiac Surgery, Papa Giovanni XXII Hospital of Bergamo, Bergamo, Italy.
⁶ Division of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
⁷ Division of Cardiac Surgery, San Camillo Forlanini Hospital, Rome, Italy.

Abstract

[This corrects the article DOI: 10.3389/ti.2023.11675.].

Keywords: HeartMate3; HeartWare; continuous-flow LVAD; full-magnetic levitation pump; hybrid levitation system pump.